MedPath

Theta-Burst-Stimulation in Early Rehabilitation of Stroke

Phase 2
Completed
Conditions
Stroke
Interventions
Device: Magstim Super Rapid2 System, sham-stimulation (in iTBS)
Device: Magstim Super Rapid2 System, intermittent theta-burst-stimulation (iTBS) protocol
Registration Number
NCT02910024
Lead Sponsor
University of Cologne
Brief Summary

The present prospective, randomized, controlled, double-blinded trial investigates the effects of intermittent theta-burst stimulation (iTBS) during the early rehabilitation after stroke. Patients with hemipresis will receive either sham or real iTBS over their affected hemispheres before occupational therapy for 8 days. Motor recovery is assessed one day after the intervention phase and three months after enrollment.

Detailed Description

To date, rehabilitation of stroke with hemiparesis mainly includes physiotherapy and occupational therapy. Yet, the majority of patients retain movement impairment relevant for activities of daily living. One explanation for this deficit is the insufficient recovery of connectivity between brain regions after stroke. It is possible to modulate this process by repetitive transcranial magnetic stimulation (rTMS) using the protocol of intermittent theta-burst stimulation (iTBS). Previous data indicate that modulation of the motor cortex with iTBS enhances the effects of subsequent motor training. The present study aims at investigating whether daily repetitive transcranial magnetic stimulation over 8 days combined with subsequent physiotherapy leads to better motor recovery, compared with physiotherapy after sham stimulation. In the first weeks and after three months, motor function, degree of disability and quality of life are examined in order to evaluate the effects of iTBS in the rehabilitation of stroke patients.

Amendment (approved by the Ethics-Committee of the Medical Faculty of the University of Cologne, 20/12/2016): Specification of exclusion criteria.

Amendment (approved by the Ethics-Committee of the Medical Faculty of the University of Cologne, 15/11/2018): Change of inclusion and exclusion criteria.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • written consent
  • age: 40-90 years
  • ischemic stroke
  • hemiparesis with impaired hand motor function
Exclusion Criteria
  • Subjects who are legally detained in an official institute (§20 MPG)
  • Participation in clinical trial within the last 12 weeks
  • Electronic implants or ferromagnetic Implants located in the head, neck or thorax (e.g. clips, intracranial shunt, artificial heart valve, pacemaker)
  • Medication pump (e.g. insulin pump)
  • Metal splinters in eye or head
  • Pregnancy / breastfeeding
  • Severe Neurodegenerative disease
  • Severe Neuroinflammatory disease
  • History of seizures / epilepsy
  • Physical addiction to alcohol, medication, or drugs (excluded: nicotine)
  • Insufficient compliance
  • Present or past malignant tumor involving the central nervous system
  • Severe Psychiatric disease
  • Clinically manifest bilateral hemiparesis or infarcts in the primary motor cortex or along the tractus corticospinalis in the hemisphere ipsilateral to the hemiparesis
  • Pre-existing cerebral infarctions with hemiparesis or pre-existing cerebral infarctions in the primary motor cortex or along the tractus corticospinalis, excluding microangiopathic changes (e.g. clinically asymptomatic lacunae <1cm)
  • Known brain lesion (surgical, traumatic)
  • Evidence for enhanced cerebral pressure
  • Severe cardial dysfunction
  • life expectancy < 12 months
  • NIHSS Score > 20
  • Blood glucose imbalances resistant to treatment (<50 mg/dl or >300 mg/dl)
  • Elevated blood pressure resistant to treatment (RR > 185/110mmHg)
  • Systemic Thrombolysis using r-tPA or thrombectomy within the last 24 hours before enrollment in study
  • Medication with benzodiazepines, high-potency antipsychotics or tricyclic antidepressants before hospitalization or long-term during hospitalization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham-rTMSMagstim Super Rapid2 System, sham-stimulation (in iTBS)Repetitive transcranial magnetic stimulation (rTMS) in sham position (tilted coil over parieto-occipital vertex) before physiotherapy for 8 days
Real-rTMSMagstim Super Rapid2 System, intermittent theta-burst-stimulation (iTBS) protocolRepetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex in the lesioned hemisphere using the intermittent theta-burst-stimulation protocol (iTBS; application of 3 pulses with a frequency of 50 Hz, in a theta-rhythm of 5 Hz for 2 seconds, repeated every 10 seconds, duration of one session: about 3,5 minutes) before physiotherapy for 8 days
Primary Outcome Measures
NameTimeMethod
Relative grip force3 months after enrollment

grip force as measured with vigorimeter

Secondary Outcome Measures
NameTimeMethod
Relative grip forceafter 8 days of intervention, and 3 months after enrollment

grip force as measured with vigorimeter

Degree of disabilityafter 8 days of intervention, and 3 months after enrollment

modified Rankin Scale, mRS

Quality of lifeafter 8 days of intervention, and 3 months after enrollment

EuroQol 5D questionnaire, EQ-5D

Stroke severityafter 8 days of intervention, and 3 months after enrollment

National Instituts of Health Stroke Scale, NIHSS

Days of rehabilitation after intervention phase3 months after enrollment

Days of rehabilitation after intervention phase as documented by external rehabilitation facility

Activities of daily living at admission and discharge in external rehabilitation facility3 months after enrollment

Barthel-Index (BI) scores as documented by external rehabilitation facility

Motor functionafter 8 days of intervention, and 3 months after enrollment

Fugl-Meyer Motor Scale of the upper extremity, FM

Motorcortex excitabilityafter 8 days of intervention, and 3 months after enrollment

Resting motor threshold as measured by stimulation of the affected motor cortex, RMT

Trial Locations

Locations (1)

Klinik und Poliklinik für Neurologie, Universitätsklinikum Köln

🇩🇪

Cologne, North Rhine-Westphalia, Germany

© Copyright 2025. All Rights Reserved by MedPath